Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289390 · ClinicalTrials.gov registry record
Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 11
- Enrollment target
NCT03289390: Completed study, sponsored by Albany Medical College.
NCT03289390 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03289390 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This study will evaluate the use of acetaminophen in preterm infants when a patent ductus arteriosus (PDA) is of concern. We will perform two simultaneous prospective observational studies over a 3 year period. The first will be of infants with clinically significant PDAs beyond 14 days of life who are medically treated with acetaminophen as a means to avoid surgical ligation, and the second will be of infants who received acetaminophen for a PDA closure during the first 2 weeks of life as a result of ibuprofen, the current standard of care in our NICU, contraindication due to medical status.
Primary Outcome
PDA will be evaluated by echocardiography to determined whether it has closed after treatment is complete.
Interventions
- DRUG Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-06-30 |
What the finished NCT03289390 record still lists
NCT03289390 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Acetaminophen is the first listed.
NCT03289390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03289390 about?
NCT03289390 is a clinical study titled "Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications". This study will evaluate the use of acetaminophen in preterm infants when a patent ductus arteriosus (PDA) is of concern. We will perform two simultaneous prospective observational studies over a 3 year period. The first will be of infants with clinically significant PDAs beyond 14 days of life who ...
What is the current status of trial NCT03289390?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-08-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03289390?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03289390?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI